Testing effectiveness (Phase 2)UnknownNCT03910803What this trial is testingTreatment of Moderate Hidradenitis SuppurativaWho this might be right forHidradenitis Suppurativa Florida Academic Dermatology Centers 20
Not applicableLooking for participantsNCT04115566What this trial is testingHidradenitis Suppurativa Prospective Observational Registry and Biospecimen RepositoryWho this might be right forHidradenitis Suppurativa University of California, San Francisco 3,000
Not applicableUnknownNCT04792957What this trial is testingJAK-STAT Signaling Pathway in Pyoderma GangrenosumWho this might be right forPyoderma GangrenosumHidradenitis SuppurativaPsoriasis Dokuz Eylul University 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06932003What this trial is testingExplore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Patients With Hidradenitis SuppurativaWho this might be right forHidradenitis Suppurativa (HS) Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. 12
Testing effectiveness (Phase 2)Looking for participantsNCT06524635What this trial is testingAssess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of LutikizumabWho this might be right forHidradenitis SuppurativaAtopic Dermatitis AbbVie 60
Large-scale testing (Phase 3)Active Not RecruitingNCT06468228What this trial is testingAssess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis SuppurativaWho this might be right forHidradenitis Suppurativa AbbVie 1,400
Testing effectiveness (Phase 2)Ended earlyNCT04414514What this trial is testingTopical Ruxolitinib 1.5% for Hidradenitis Suppurativa TreatmentWho this might be right forHidradenitis Suppurativa Milton S. Hershey Medical Center 6
Testing effectiveness (Phase 2)Study completedNCT04756336What this trial is testingLTX-109 as Treatment for Hidradenitis SuppurativaWho this might be right forHidradenitis Suppurativa Pharma Holdings AS 11
Testing effectiveness (Phase 2)Study completedNCT05849922What this trial is testingTest the Efficacy and Safety of SAR442970 in Adults With Hidradenitis SuppurativaWho this might be right forHidradenitis Suppurativa Sanofi 86
Testing effectiveness (Phase 2)Study completedNCT05103423What this trial is testingSafety and Efficacy Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)Who this might be right forHidradenitis Suppurativa Staidson (Beijing) Biopharmaceuticals Co., Ltd 50
Not applicableLooking for participantsNCT06324552What this trial is testingDefects of Keratinocytes Function in Dermatologic PatientsWho this might be right forHidradenitis Suppurativa IRCCS Burlo Garofolo 50
Testing effectiveness (Phase 2)Study completedNCT03628924What this trial is testingEvaluate the Efficacy, Safety, and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS)Who this might be right forHidradenitis Suppurativa Janssen Research & Development, LLC 184
Large-scale testing (Phase 3)Looking for participantsNCT06959225What this trial is testingStudy to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)Who this might be right forHidradenitis Suppurativa Incyte Corporation 550
Testing effectiveness (Phase 2)Study completedNCT00329823What this trial is testingEtanercept in Hidradenitis SuppurativaWho this might be right forHidradenitis Suppurativa University of Athens 10
Not applicableLooking for participantsNCT07282015What this trial is testingReal-world Secukinumab Outcomes in Canadian HS PatientsWho this might be right forHidradenitis Suppurativa Novartis Pharmaceuticals 142
Not applicableActive Not RecruitingNCT06785675What this trial is testingAssessing Short-term Treatment Satisfaction and Quality of Life in Patients With Hidradenitis Suppurativa Initiated on Secukinumab.Who this might be right forHidradenitis Suppurativa Novartis Pharmaceuticals 48
Testing effectiveness (Phase 2)Study completedNCT03569371What this trial is testingThe Safety of INCB054707 in Participants With Hidradenitis SuppurativaWho this might be right forHidradenitis Suppurativa Incyte Corporation 10
Not applicableWithdrawnNCT05255575What this trial is testingA Single Center, Prospective Clinical Trial of Intravenous Ertapenem in the Treatment of Hurley Stage II or III Hidradenitis SuppurativaWho this might be right forHidradenitis Suppurativa Henry Ford Health System
Large-scale testing (Phase 3)Active Not RecruitingNCT06840392What this trial is testingAssess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis SuppurativaWho this might be right forHidradenitis Suppurativa Novartis Pharmaceuticals 565
Not applicableLooking for participantsNCT06599411What this trial is testingIdentification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin DiseasesWho this might be right forAtopic DermatitisPsoriasisHidradenitis Suppurativa+9 more Assistance Publique - Hôpitaux de Paris 830